Inhibition of GSK 3β Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Ma, Renqiang ^a   Wei, Yi ^a   Huang, Xiaoming ^b   Fu, Ran ^a   Luo, Xi ^a   Zhu, Xiaolin ^a   Lei, Wenbin ^a   Fang, Jugao ^c   Li, Huabin ^a   Wen, Weiping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EZH2;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION;

AMINO ACID MOTIFS; ANALYSIS OF VARIANCE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; POLYCOMB REPRESSIVE COMPLEX 2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 84880436285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068614     Document Type: Article

References (26)

1. Chou J, Lin YC, Kim J, You L, Xu Z, et al. (2008) Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Head Neck 30: 946-63.
2. Tao Q, Chan AT, (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9: 1-24.
3. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, et al. (2003) Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 56: 1046-54.
4. Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, et al. (2012) EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 31: 583-94.
5. Lu J, He ML, Wang L, Chen Y, Liu X, et al. (2011) MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 71: 225-33.
6. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: p. 624-9.
7. Forde JE, Dale TC, (2007) Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 64: 1930-44.
8. Luo J, (2009) Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 273: 194-200.
9. Manoukian AS, Woodgett JR, (2002) Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 84: 203-29.
10. Schaffer B, Wiedau-Pazos M, Geschwind DH, (2003) Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302: 73-81.
11. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, et al. (2001) The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9: 1143-52.
12. Huang XM, Dai CB, Mou ZL, Wang LJ, Wen WP, et al. (2009) Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy. Cancer Lett 279: 47-56.
13. Liu Y, Zhou Y, Zhu K, (2012) Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7: e45910.
14. Sun W, Guo MM, Han P, Lin JZ, Liang FY, et al. (2012) Id-1 and the p65 subunit of NF-?B promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis 33: 810-7.
15. Viré E, Brenner C, Deplus R, Blanchon L, Fraga M, et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-4.
16. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, et al. (2010) Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 1: e85.
17. Hwang CF, Huang HY, Chen CH, Chien CY, Hsu YC, et al. (2012) Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth. Int J Radiat Oncol Biol Phys 82: 597-604.
18. Grimes CA, Jope RS, (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426.
19. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-86.
20. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, et al. (2005) Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res 65: 5792-801.
21. Swart R, Ruf IK, Sample J, Longnecker R, (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74: 10838-45.
22. Morrison JA, Klingelhutz AJ, Raab-Traub N, (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 77: 12276-84.
23. Fang J, Lei W, Huang X, Li P, Chen X, et al. (2012) Expression of mismatch repair gene PMS2 in nasopharyngeal carcinoma and regulation by glycogen synthase kinase-3ß in vivo and in vitro. Auris Nasus Larynx 39: 71-6.
24. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N, (2004) Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64: 5251-60.
25. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, et al. (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27: 7274-84.
26. Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, et al. (2010) An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med 16: 286-94.